121 related articles for article (PubMed ID: 28751412)
1. Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study.
Le Mao R; Tromeur C; Bazire A; Gouillou M; Guegan M; Lacut K; Delluc A; Mottier D; Leroyer C; Couturaud F
Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28751412
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study.
Mollard LM; Le Mao R; Tromeur C; Le Moigne E; Gouillou M; Pan-Petesch B; Delluc A; Couturaud F; Lacut K
Eur J Intern Med; 2018 Jun; 52():22-27. PubMed ID: 29548526
[TBL] [Abstract][Full Text] [Related]
3. COPD and risk of venous thromboembolism and mortality in a general population.
Børvik T; Brækkan SK; Enga K; Schirmer H; Brodin EE; Melbye H; Hansen JB
Eur Respir J; 2016 Feb; 47(2):473-81. PubMed ID: 26585434
[TBL] [Abstract][Full Text] [Related]
4. Chronic Obstructive Pulmonary Disease and Risk of Mortality in Patients with Venous Thromboembolism-The Tromsø Study.
Børvik T; Brækkan SK; Evensen LH; Brodin EE; Morelli VM; Melbye H; Hansen JB
Thromb Haemost; 2020 Mar; 120(3):477-483. PubMed ID: 31887782
[TBL] [Abstract][Full Text] [Related]
5. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
[TBL] [Abstract][Full Text] [Related]
7. Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study.
Kubota Y; London SJ; Cushman M; Chamberlain AM; Rosamond WD; Heckbert SR; Zakai N; Folsom AR
J Thromb Haemost; 2016 Dec; 14(12):2394-2401. PubMed ID: 27696765
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
[TBL] [Abstract][Full Text] [Related]
9. The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.
Yhim HY; Jang MJ; Kwak JY; Yim CY; Choi WI; Lee YC; Lee JO; Lee KW; Bang SM; Kim SH; Kim YK; Chang HJ; Oh D;
Thromb Res; 2013 Apr; 131(4):e133-40. PubMed ID: 23399441
[TBL] [Abstract][Full Text] [Related]
10. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
11. B blood group: A strong risk factor for venous thromboembolism recurrence.
Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and outcome of venous thromboembolism in COPD.
Bertoletti L; Quenet S; Mismetti P; Hernández L; Martín-Villasclaras JJ; Tolosa C; Valdés M; Barrón M; Todolí JA; Monreal M;
Eur Respir J; 2012 Apr; 39(4):862-8. PubMed ID: 21885395
[TBL] [Abstract][Full Text] [Related]
13. Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study.
Gándara E; Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; Le Gal G; Solymoss S; Crowther M; Carrier M; Langlois N; Kovacs J; Little Ma J; Carson N; Ramsay T; Rodger MA
Thromb Haemost; 2013 Dec; 110(6):1172-9. PubMed ID: 24067945
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
[TBL] [Abstract][Full Text] [Related]
15. The prevalence and risk factors of venous thromboembolism in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease.
Pang H; Wang L; Liu J; Wang S; Yang Y; Yang T; Wang C
Clin Respir J; 2018 Nov; 12(11):2573-2580. PubMed ID: 30207643
[TBL] [Abstract][Full Text] [Related]
16. Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort Study.
Girard P; Laporte S; Chapelle C; Falvo N; Falchero L; Cloarec N; Monnet I; Burnod A; Tomasini P; Boulon C; Debourdeau P; Boutruche B; Scotté F; Lamblin A; Meyer G
Thromb Haemost; 2022 Jan; 122(1):151-157. PubMed ID: 33878800
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
[TBL] [Abstract][Full Text] [Related]
18. The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study.
Giorgi Pierfranceschi M; Donadini MP; Dentali F; Ageno W; Marazzi M; Bocchi R; Imberti D
Thromb Haemost; 2013 Jan; 109(1):34-8. PubMed ID: 23223906
[TBL] [Abstract][Full Text] [Related]
19. Predictors of recurrence of cancer-associated venous thromboembolism after discontinuation of anticoagulant therapy: a multicenter cohort study.
Lapébie FX; Bura-Rivière A; Espitia O; Bongard V; Ciammaichella MM; Martínez JG; Sigüenza P; Giménez JC; Bertoletti L; Monreal M
J Thromb Haemost; 2023 Aug; 21(8):2189-2201. PubMed ID: 37068594
[TBL] [Abstract][Full Text] [Related]
20. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.
Baglin T; Luddington R; Brown K; Baglin C
Lancet; 2003 Aug; 362(9383):523-6. PubMed ID: 12932383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
